The Venus Times

The Venus Times

E-Newsletter

Venus Remedies partner
News Featured

Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India

Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
2 min read
Venus Remedies Secures GMP Certification from Moldova for Antibiotic-Carbapenem Manufacturing Facility

Venus Remedies Secures GMP Certification from Moldova for Antibiotic-Carbapenem Manufacturing Facility

Venus Remedies proudly announces its latest achievement: receiving Good Manufacturing Practices (GMP) certification from the Ministry of Health of Moldova for its antibiotic-carbapenem manufacturing facility. This certification was granted after a comprehensive inspection conducted in October 2024, with final approval granted in December 2024. This achievement reaffirms the company’s
1 min read
image image image image image